Collegium Pharmaceutical, Inc. COLL Interest Income
Interest Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s interest income?
- Collegium Pharmaceutical, Inc. (COLL) reported interest income of $3.71M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s interest income changed year-over-year?
- Collegium Pharmaceutical, Inc.'s interest income increased by 66.6% year-over-year, from $2.23M to $3.71M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s interest income?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s interest income has grown at a 453.8% compound annual growth rate (CAGR), from $12K to $11.29M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.